Report overview
Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
This report aims to provide a comprehensive presentation of the global market for Conjugate Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conjugate Vaccines. This report contains market size and forecasts of Conjugate Vaccines in global, including the following market information:
Global Conjugate Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Conjugate Vaccines Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Conjugate Vaccines companies in 2022 (%)
The global Conjugate Vaccines market was valued at US$ 10280 million in 2022 and is projected to reach US$ 13090 million by 2029, at a CAGR of 3.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Market competition is intense. Pfizer, GSK, Sanofi, Merck, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 86.11% market share in 2019.
We surveyed the Conjugate Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Conjugate Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Conjugate Vaccines Market Segment Percentages, by Type, 2022 (%)
Monovalent Conjugate Vaccines
Multivalent Conjugate Vaccines
Global Conjugate Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Conjugate Vaccines Market Segment Percentages, by Application, 2022 (%)
Children
Adults
Global Conjugate Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Conjugate Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Conjugate Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Conjugate Vaccines revenues share in global market, 2022 (%)
Key companies Conjugate Vaccines sales in global market, 2018-2023 (Estimated), (Units)
Key companies Conjugate Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Neuron Biotech
Serum Institute of India
Pfizer
Sanofi Pasteur
Bharat Biotech
Biological
GlaxoSmithKline
Merck
CSL
Outline of Major Chapters:
Chapter 1: Introduces the definition of Conjugate Vaccines, market overview.
Chapter 2: Global Conjugate Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Conjugate Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Conjugate Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Conjugate Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
